HIGHLIGHTS OF PRESCRIBING INFORMATION
These highlights do not include all the information needed to use EXEMESTANE safely and effectively. See full prescribing information for EXEMESTANE.
EXEMESTANE tablets, for oral use
Initial U.S. Approval: 1999
INDICATIONS AND USAGE
EXEMESTANE is an aromatase inhibitor indicated for:
DOSAGE AND ADMINISTRATION
Recommended Dose: One 25 mg tablet once daily after a meal (2.1).
DOSAGE FORMS AND STRENGTHS
Tablets: 25 mg (3).
Patients with a known hypersensitivity to the drug or to any of the excipients (4).
WARNINGS AND PRECAUTIONS
To report SUSPECTED ADVERSE REACTIONS, contact Greenstone LLC at 1-800-438-1985 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
USE IN SPECIFIC POPULATIONS
Lactation: Advise not to breastfeed (8.2).
See 17 for PATIENT COUNSELING INFORMATION and FDA-approved patient labeling.
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.